These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 17135183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA, Roberts MS, Robertson TA, Dalley AJ, Lipman J.
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J.
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [Abstract] [Full Text] [Related]

  • 6. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
    Pertel PE, Bernardo P, Fogarty C, Matthews P, Northland R, Benvenuto M, Thorne GM, Luperchio SA, Arbeit RD, Alder J.
    Clin Infect Dis; 2008 Apr 15; 46(8):1142-51. PubMed ID: 18444848
    [Abstract] [Full Text] [Related]

  • 7. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG, Woods GL, Jiang Q, Gesser RM.
    J Antimicrob Chemother; 2004 Jun 15; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [Abstract] [Full Text] [Related]

  • 8. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
    Lorente L, Lorenzo L, Martín MM, Jiménez A, Mora ML.
    Ann Pharmacother; 2006 Feb 15; 40(2):219-23. PubMed ID: 16449546
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Infections in a surgical intensive care unit of a university hospital in Greece.
    Markogiannakis H, Pachylaki N, Samara E, Kalderi M, Minettou M, Toutouza M, Toutouzas KG, Theodorou D, Katsaragakis S.
    Int J Infect Dis; 2009 Mar 15; 13(2):145-53. PubMed ID: 18775663
    [Abstract] [Full Text] [Related]

  • 11. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 15; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study.
    Chastre J, Wunderink R, Prokocimer P, Lee M, Kaniga K, Friedland I.
    Crit Care Med; 2008 Apr 15; 36(4):1089-96. PubMed ID: 18379232
    [Abstract] [Full Text] [Related]

  • 13. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM, Mandell LA, Tillotson G, Kostov K, Georgiev O.
    J Antimicrob Chemother; 2007 Jul 15; 60(1):112-20. PubMed ID: 17537866
    [Abstract] [Full Text] [Related]

  • 14. A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.
    Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Udy AA, Paul SK, Lipman J, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australasian Society for Infectious Diseases Clinical Research Network.
    Crit Care Resusc; 2013 Sep 15; 15(3):179-85. PubMed ID: 23944203
    [Abstract] [Full Text] [Related]

  • 15. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.
    Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J.
    Clin Infect Dis; 2013 Jan 15; 56(2):236-44. PubMed ID: 23074313
    [Abstract] [Full Text] [Related]

  • 16. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
    Adembri C, Fallani S, Cassetta MI, Arrigucci S, Ottaviano A, Pecile P, Mazzei T, De Gaudio R, Novelli A.
    Int J Antimicrob Agents; 2008 Feb 15; 31(2):122-9. PubMed ID: 18055183
    [Abstract] [Full Text] [Related]

  • 17. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M, Südhoff T, Fenchel K, Egerer G, Kämpfe D, Ritter J, Franke A, Heil G, Peters G, Jürgens H.
    Wien Med Wochenschr; 1998 Feb 15; 148(21):481-7. PubMed ID: 10048176
    [Abstract] [Full Text] [Related]

  • 18. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis.
    Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J.
    Int J Antimicrob Agents; 2010 Feb 15; 35(2):156-63. PubMed ID: 20018492
    [Abstract] [Full Text] [Related]

  • 19. Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial.
    Eid A, Wiedermann CJ, Kinasewitz GT.
    Anesth Analg; 2008 Nov 15; 107(5):1633-8. PubMed ID: 18931224
    [Abstract] [Full Text] [Related]

  • 20. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial.
    Beale RJ, Sherry T, Lei K, Campbell-Stephen L, McCook J, Smith J, Venetz W, Alteheld B, Stehle P, Schneider H.
    Crit Care Med; 2008 Jan 15; 36(1):131-44. PubMed ID: 18007263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.